13.840

-0.350 (-2.47%)
Range 13.150 - 14.590   (10.95%)
Open 14.010
Previous Close 14.190
Buy Price 13.760
Buy Volume 31
Sell Price 13.750
Sell Volume 10
Volume 284,384
Value -
Remark
Measurement Type Value
EPS (USD) -5.507
Trailing EPS (USD) -7.034
NAV (USD) 4.067
Cash In Hand (USD) 4.222
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 3.489
Price / Cash In Hand 3.361
Issued & Paid-up Shares 3,793,240
Treasury Shares -
Market Cap (M) 53.826
Par Value (USD) n.a.
Beta - 75 Days 1.552
R-Squared - 75 Days(%) 3.5
Beta - 500 Days 0.961
R-Squared - 500 Days(%) 0.02
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 05 Aug 2020 04:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 06 Aug 2020
View All Events

About DARIOHEALTH CORP

Labstyle Innovations Corp is an Israel-based developer of the Dario diabetes management solution. It is engaged in developing and commercializing patent-pending technology that is seeking to bring clinical laboratory testing capabilities to consumers through the use of smartphones. The Company’s initial product is Dario, which is a device and software system for patient self-monitoring of blood glucose (SMBG). Dario is a patent pending system, which combines an all-in-one SMBG device consisting of a lancet to obtain a blood sample, a device-specific disposable test strip cartridge and a smartphone driven glucose reader adaptor to hold the strip and interface with the smartphone, coupled with a smartphone application and Internet-based data services. Dario will offer millions of diabetics, and in particular insulin dependent diabetics, a new option to the SMBG test kits.

Loading Chart...